{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T15:57:16Z","timestamp":1790783836364,"version":"4.1.0"},"reference-count":62,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0121099","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T19:11:58Z","timestamp":1427915518000},"page":"e0121099","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":45,"title":["Screening of the Pan-African Natural Product Library Identifies Ixoratannin A-2 and Boldine as Novel HIV-1 Inhibitors"],"prefix":"10.1371","volume":"10","author":[{"given":"Ian","family":"Tietjen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fidele","family":"Ntie-Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Mwimanzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pascal Amoa","family":"Ongu\u00e9n\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret A.","family":"Scull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas Oyebode","family":"Idowu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abiodun Oguntuga","family":"Ogundaini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc Mbaze","family":"Meva\u2019a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berhanu M.","family":"Abegaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerstin","family":"Andrae-Marobela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Brockman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zabrina L.","family":"Brumme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fedida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2015,4,1]]},"reference":[{"key":"ref1","unstructured":"UNAIDS. UNAIDS Access to antiretroviral therapy in Africa\u2014Status report on progress towards the 2015 targets. Available: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2013\/20131219_AccessARTAfricaStatusReportProgresstowards2015Targets_en.pdf\" xlink:type=\"simple\">www.unaids.org\/en\/media\/unaids\/contentassets\/documents\/unaidspublication\/2013\/20131219_AccessARTAfricaStatusReportProgresstowards2015Targets_en.pdf<\/ext-link>. Accessed 2014 Oct 22."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"392","DOI":"10.2174\/13892002113149990095","article-title":"Polyphenols: a diverse class of multi-target andi-HIV-1 agents","volume":"14","author":"K Andrae-Marobela","year":"2013","journal-title":"Curr Drug Metab"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nrd2512","article-title":"Raltegravir","volume":"7","author":"SG Deeks","year":"2008","journal-title":"Nat Rev Drug Discov"},{"key":"ref4","first-page":"236","article-title":"Integrase inhibitors to treat HIV\/AIDS","volume":"4","author":"Y Porrimer","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"ref5","first-page":"642","article-title":"2014 update on the drug resistance mutations in HIV-1","volume":"22","author":"AM Wensing","year":"2014","journal-title":"Top Antivir Med"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S1473-3099(11)70149-9","article-title":"HIV-1 drug resistance in antiretroviral-na\u00efve individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study","volume":"11","author":"RL Hamers","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.2174\/138955708785909943","article-title":"Antiviral activity of phytochemicals: a comprehensive review","volume":"8","author":"R Naithani","year":"2008","journal-title":"Mini Rev Med Chem"},{"key":"ref8","first-page":"127","article-title":"Drug Discovery in Africa: impacts of genomics, natural products, traditional medicines, insights into medicinal chemistry, and technology platforms in pursuit of new drugs","author":"TG Geary","year":"2012"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"e90655","DOI":"10.1371\/journal.pone.0090655","article-title":"Virtualizing the p-ANAPL library: A step towards drug discovery from African medicinal plants","volume":"9","author":"F Ntie-Kang","year":"2014","journal-title":"PLOS ONE"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.bbamem.2013.08.017","article-title":"Viral channel proteins in intracellular protein-protein communication: Vpu of HIV-1, E5 of HPV16 and p7 of HCV","volume":"1838","author":"WB Fischer","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.bbamem.2013.06.029","article-title":"HIV-1 Vpu\u2014an ion channel in search of a job","volume":"1838","author":"K Strebel","year":"2014","journal-title":"Biochim Biophys Acta"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1006\/viro.2001.1244","article-title":"Deletion of the Vpu sequences prior to the env in a simian-human immunodeficiency virus results in enhanced env precursor synthesis but is less pathogenic for pig-tailed macaques","volume":"293","author":"EB Stephens","year":"2002","journal-title":"Virology"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"7108","DOI":"10.1128\/JVI.70.10.7108-7115.1996","article-title":"The Vpu protein of human immunodeficiency virus type 1 forms cation-selective ion channels","volume":"70","author":"GD Ewart","year":"1996","journal-title":"J Virol"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S0014-5793(96)01146-5","article-title":"Identification of an ion channel activity of the Vpu transmembrane domain and its involvement in the regulation of virus release from HIV-1\u2014infected cells","volume":"398","author":"U Schubert","year":"1996","journal-title":"FEBS Lett"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.virol.2011.04.009","article-title":"Ion channel activity of HIV-1 Vpu is dispensable for counteraction of CD317","volume":"416","author":"S Bolduan","year":"2011","journal-title":"Virology"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1006\/viro.1998.9087","article-title":"Effects of Vpu expression on Xenopus oocyte membrane conductance","volume":"244","author":"MJ Coady","year":"1998","journal-title":"Virology"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/j.drudis.2012.05.002","article-title":"Viral targets of acylguanidines","volume":"17","author":"EV Gazina","year":"2012","journal-title":"Drug Discov Today"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1128\/AAC.48.6.2325-2330.2004","article-title":"Potential new anti-human immunodeficiency virus type 1 compounds depress virus replication in cultured human macrophages","volume":"48","author":"GD Ewart","year":"2004","journal-title":"Antimicrob Agents Chemother"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1128\/AAC.01308-09","article-title":"Antiviral efficacy of the novel compound BIT225 against HIV-1 release from human macrophages","volume":"54","author":"G Khohury","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3559","DOI":"10.1007\/s00216-010-3498-x","article-title":"Ligand-protein docking studies of potential HIV-1 drug compounds using the algorighm FlexX","volume":"396","author":"G Patargias","year":"2010","journal-title":"Anal Bioanal Chem"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1016\/j.phytochem.2010.08.018","article-title":"Doubly linked, A-type proanthrocyanidin trimer and other constituents of <italic>Ixora coccinea<\/italic> leaves and their antioxidant and antibacterial properties","volume":"71","author":"TO Idowu","year":"2010","journal-title":"Phytochemistry"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1016\/j.fitote.2012.04.011","article-title":"Phytochemical and antimicrobial investigations of stilbenoids and flavonoids isolated from three species of Combretaceae","volume":"83","author":"DR Katerere","year":"2012","journal-title":"Filoterapia"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1039\/b803784c","article-title":"Knipholone and related 4-phenylanthraquinones: structurally, pharmacologically, and biosynthetically remarkable natural products","volume":"25","author":"G Bringmann","year":"2008","journal-title":"Nat Prod Rep"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1002\/ptr.1481","article-title":"The interaction of selected natural products with human recombinant glutathione transferases","volume":"18","author":"R Hayeshi","year":"2004","journal-title":"Phytother Res"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1021\/np030061l","article-title":"Bulbinelonesidea A-E, phenylanthraquinone glycosides from the roots of Bulbinella floribunda","volume":"66","author":"M Kuroda","year":"2003","journal-title":"J Nat Prod"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.jviromet.2005.08.003","article-title":"Use of a novel GFP reporter cell line to examine replication capacity of CXCR4- and CCR5-tropic HIV-1 by flow cytometry","volume":"131","author":"MA Brockman","year":"2006","journal-title":"J Viral Methods"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1126\/science.1114016","article-title":"Complete replication of hepatitis C virus in cell culture","volume":"309","author":"BD Lindenbach","year":"2005","journal-title":"Science"},{"key":"ref28","unstructured":"Ewart GD, Luscombe CA, Miller M. Hepatitis C antiviral compositions and methods. 1996;WO 2009018609 A1."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1089\/aid.1994.10.343","article-title":"Construction and <italic>in vitro<\/italic> properties of HIV-1 mutants with deletions in \u201cnonessential\u201d genes","volume":"10","author":"JS Gibbs","year":"1994","journal-title":"AIDS Res Hum Retroviruses"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1002\/(SICI)1096-987X(199604)17:6<490::AID-JCC1>3.3.CO;2-V","article-title":"Merck molecular forcefield","volume":"17","author":"TA Halgren","year":"1996","journal-title":"J Comput Chem"},{"key":"ref31","unstructured":"Chemical Computing Group Inc: <italic>Molecular Operating Environment Software<\/italic>. Montreal; 2010."},{"key":"ref32","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1021\/ci980153u","article-title":"Definition of a pharmacophore for partial agonists of serotonin 5-HT3 receptors","volume":"39","author":"C Daveu","year":"1999","journal-title":"J Chem Info Comput Sci"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-4690-10-1","article-title":"Attenuation of multiple Nef functions in HIV-1 elite controllers","volume":"10","author":"P Mwimanzi","year":"2013","journal-title":"Retrovirology"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1097\/QAI.0b013e3181fe9450","article-title":"Reduced replication capacity of NL4-3 recombinant viruses encoding reverse transcriptase-integrase sequences from HIV-1 elite controllers","volume":"56","author":"ZL Brumme","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"364-3","DOI":"10.1002\/hep.22673","article-title":"Development and characterization of hepatitis C virus genotype 1\u20137 cell culture systems: role of CD81 and scavenger receptor class B type I and effect of antiviral drugs","volume":"49","author":"JM Gottwein","year":"2009","journal-title":"Hepatology"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"e27660","DOI":"10.1371\/journal.pone.0027660","article-title":"The HIV-1 Vpu viroporin inhibitor BIT225 does not affect Vpu-mediated tetherin antagonism","volume":"6","author":"BD Kuhl","year":"2011","journal-title":"PLOS ONE"},{"key":"ref37","first-page":"113","article-title":"Hepatitis C virus proteins: From structure to function","volume":"369","author":"D Moradpour","year":"2013","journal-title":"Curr Top Microbiol Immunol"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1002\/hep.22555","article-title":"Genotype-dependent sensitivity of hepatitis C virus to inhibitors of the p7 ion channel","volume":"48","author":"S Griffin","year":"2008","journal-title":"Hepatology"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.antiviral.2010.02.312","article-title":"A novel hepatitis C virus p7 ion channel inhibitor, BIT225, inhibits bovine viral diarrhea virus in vitro and shows synergism with recombinant interferon-\u03b1-2b and nucleoside analogues","volume":"86","author":"CA Luscombe","year":"2010","journal-title":"Antivir Res"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.antiviral.2013.10.006","article-title":"Differential effect of p7 inhibitors on hepatitis C virus cell-to-cell transmission","volume":"100","author":"LW Meredith","year":"2013","journal-title":"Antivir Res"},{"key":"ref41","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.clim.2010.08.007","article-title":"The evaluation of catechins that contain a galloyl moiety as potential HIV-1 integrase inhibitors","volume":"137","author":"F Jiang","year":"2010","journal-title":"Clin Immunol"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1016\/S0960-894X(01)00577-7","article-title":"Simplified catechin-gallate inhibitors of HIV-1 reverse transcriptase","volume":"11","author":"LM Tillekeratne","year":"2001","journal-title":"Bioorg Med Chem Lett"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/j.drudis.2012.02.015","article-title":"Catechins containing a galloyl moiety as potential anti-HIV-1 compounds","volume":"17","author":"Y Zhao","year":"2012","journal-title":"Drug Disc Today"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1055\/s-0034-1368583","article-title":"Genistein as antiviral drug against HIV ion channel","volume":"80","author":"D Sauter","year":"2014","journal-title":"Planta Med"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cbi.2005.09.002","article-title":"Boldine and its antioxidant or health-promoting properties","volume":"159","author":"P O\u2019Brien","year":"2006","journal-title":"Chem Biol Interact"},{"key":"ref46","unstructured":"Lau YS, Ling WC, Murugan D, Mustafa MR. Boldine ameliorates vascular oxidative stress and endothelial dysfunction: Therapeutic implication for hypertension and diabetes. J Cardiovasc Pharmacol. 2014; in press. <comment>doi: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/dx.doi.org\/10.1097\/FJC.0185\" xlink:type=\"simple\">10.1097\/FJC.0185<\/ext-link><\/comment>"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.bmc.2004.10.020","article-title":"Anti-HIV benzylisoquinoline alkaloids and flavonoids from the leaves of <italic>Nelumbo nucifera<\/italic>, and structure-activity correlations with related alkaloids","volume":"13","author":"Y Kashiwada","year":"2005","journal-title":"Bioorg Med Chem"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1021\/np970382v","article-title":"Antipoliovirus structure-activity relationships of some aporphine alkaloids","volume":"61","author":"J Boustie","year":"1998","journal-title":"J Nat Prod"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"7457","DOI":"10.1016\/j.bmc.2008.06.010","article-title":"Cinnamoyl- and hydroxycinnamoyl amides of glaucine and their antioxidative and antiviral activities","volume":"16","author":"M Spasova","year":"2008","journal-title":"Bioorg Med Chem"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1055\/s-2006-958128","article-title":"Anti-herpes virus activity of aporphine alkaloids","volume":"61","author":"JA Montanha","year":"1995","journal-title":"Planta Med"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"e1002315","DOI":"10.1371\/journal.pcbi.1002315","article-title":"Two birds with one stone? Possible dual-targeting H1N1 inhibitors from traditional Chinese medicine","volume":"7","author":"SS Chang","year":"2011","journal-title":"PLOS Comput Biol"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1055\/s-0034-1368590","article-title":"Natural products as potential human ether-a-go-go-related gene channel inhibitors\u2014screening of plant-derived alkaloids","volume":"80","author":"A Schramm","year":"2014","journal-title":"Planta Med"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/nmo.12334","article-title":"Natural compounds boldine and menthol are antagonists of human 5-HT<sub>3<\/sub> receptors: implications for treating gastrointestinal disorders","volume":"26","author":"J Walstab","year":"2014","journal-title":"Neurogastroenterol Motil"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1016\/j.bmc.2007.03.023","article-title":"Aporphine metho salts as neuronal nicotinic acetylcholine receptor blockers","volume":"15","author":"P Iturriaga-V\u00e1squez","year":"2007","journal-title":"Bioorg Med Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/0014-2999(93)90445-N","article-title":"Selective action of two aporphines at \u03b1<sub>1<\/sub>-adrenoceptors and potential-operated Ca<sup>2+<\/sup> channels","volume":"231","author":"MD Ivorra","year":"1993","journal-title":"Eur J Pharmacol"},{"key":"ref56","unstructured":"Aldersley M, Corless L, Griffin S. Hepatitis C, rimantadine, and antiviral combination therapy (HepRiACT). Database: ClinicalTrials.gov. <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/clinicaltrials.gov\/show\/NCT01413490\" xlink:type=\"simple\">http:\/\/clinicaltrials.gov\/show\/NCT01413490<\/ext-link> NLM. Accessed 22 October 2014."},{"key":"ref57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1186\/1741-7015-11-234","article-title":"Managing HIV\/hepatitis C co-infection in the era of direct acting antivirals","volume":"11","author":"JK Rockstroh","year":"2013","journal-title":"BMC Medicine"},{"key":"ref58","doi-asserted-by":"crossref","first-page":"e1024","DOI":"10.1016\/j.ijid.2010.06.013","article-title":"Hepatitis B\/C in sub-Saharan Africa: an association between highly prevalent infectious diseases. A systematic review and meta-analysis","volume":"14","author":"ER Barth","year":"2010","journal-title":"Int J Infect Diseases"},{"key":"ref59","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.bbagen.2005.02.012","article-title":"Theaflavin derivatives in black tea and catechin derivatives in green tea inhibit HIV-1 entry by targeting gp41","volume":"1723","author":"S Liu","year":"2005","journal-title":"Biochim Biophys Acta"},{"key":"ref60","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1021\/np030041j","article-title":"Isolation and synthesis of a new bioactive ellagic acid derivative from <italic>Combretum yunnanensis<\/italic>","volume":"66","author":"Y Asami","year":"2003","journal-title":"J Nat Prod"},{"key":"ref61","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1128\/AAC.42.9.2245","article-title":"Human immunodeficiency virus type 1 cDNA integration: New aromatic hydroxylated inhibitors and studies of the inhibition mechanism","volume":"42","author":"CM Farnet","year":"1998","journal-title":"Antimicrob Agents Chemother"},{"key":"ref62","first-page":"540","article-title":"Ellagic acid and gallic acid from <italic>Lagerstroemia speciosa<\/italic> L inhibit HIV-1 infection through inhibition of HIV-1 protease and reverse transcriptase activity","volume":"137","author":"Nutan","year":"2013","journal-title":"Indian J Med Res"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0121099","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T10:05:15Z","timestamp":1598868315000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0121099"}},"subtitle":[],"editor":[{"given":"Michael","family":"Schindler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2015,4,1]]},"references-count":62,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2015,4,1]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0121099","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,1]]}}}